J&J has made an interesting foray into creating a translational analytic platform using i2b2. This article from Bio-ITWorld summarizes an impressive bit of work led Eric Perakslis. They have pulled together multiple private and public data sources to help accelerate their discovery and validation process. Perhaps this presages a further push into trans-enterprise intelligence at the pharmaceutical companies?
No comments:
Post a Comment